AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 100 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,283,190 | -48.3% | 201,127 | -10.2% | 0.00% | -100.0% |
| Q2 2023 | $2,483,029 | +22.3% | 223,898 | +69.3% | 0.00% | 0.0% |
| Q1 2023 | $2,029,624 | +71.5% | 132,223 | +147.9% | 0.00% | – |
| Q4 2022 | $1,183,327 | +34.2% | 53,327 | -1.3% | 0.00% | – |
| Q3 2022 | $882,000 | -26.4% | 54,039 | -34.5% | 0.00% | – |
| Q2 2022 | $1,199,000 | -19.9% | 82,544 | +1.9% | 0.00% | – |
| Q1 2022 | $1,496,000 | -49.9% | 81,009 | -35.6% | 0.00% | -100.0% |
| Q4 2021 | $2,989,000 | +1.0% | 125,770 | +4.7% | 0.00% | 0.0% |
| Q3 2021 | $2,958,000 | +79.4% | 120,112 | +80.1% | 0.00% | – |
| Q2 2021 | $1,649,000 | -13.3% | 66,709 | -23.5% | 0.00% | – |
| Q1 2021 | $1,903,000 | -7.8% | 87,241 | +7.8% | 0.00% | – |
| Q4 2020 | $2,065,000 | +37.5% | 80,924 | +51.6% | 0.00% | – |
| Q3 2020 | $1,502,000 | – | 53,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |